Table 2.
Characteristics at baseline of treatment group and control group
| Characteristics | Treatment Group (N = 17) | Control Group (N = 19) | p value |
|---|---|---|---|
| Anthropometric characteristics | |||
| Age, mean ± SD | 71.2 ± 3.1 | 72.8 ± 2.7 | 0.16 |
| Gender, n° (%) | |||
| Male | 6 (35.3) | 5 (26.3) | 0.43 |
| Female | 11 (64.7) | 14 (73.7) | |
| Weight, mean ± DS | 71.6 ± 4.6 | 74.2 ± 2.4 | 0.34 |
| BMI, mean ± DS | 24.2 ± 3.7 | 23.8 ± 2.8 | 0.71 |
| Clinical characteristics | 0.28 | ||
| Laterality, n° (%) | |||
| Right | 7 (41.2) | 11 (57.9) | |
| Left | 10 (58.8) | 8 (42.1) | |
| NRS, mean ± DS | 7.6 ± 0,93 | 7.5 ± 1,21 | 0.79 |
| Anatomical site of the fracture n° (%) | 0.56 | ||
| Pertrochanterics | 10 (58.8) | 12 (63.2) | |
| Intertrochanteric | 2 (11.7) | 1 (5.2) | |
| Subtrochanteric | 5 (29.5) | 6 (31.6) | |
| Type of surgery, n°(%) | 0.62 | ||
| Intramedullary nail | 13 (76.5) | 12 (63.2) | |
| Plate and screws | 4 (23.5) | 7 (36.8) | |
| Comorbidity, n° (%) | 0.44 | ||
| None | 0 (0) | 0 (0) | |
| 1–2 | 3 (17.6) | 5 (26.3) | |
| ≥ 3 | 14 (82.4) | 14 (73.7) | |
| Vitamin D, mean ± DS | 17.7 ± 6.21 | 19.3 ± 5.41 | 0.41 |
| Magnesemia levels, mean ± DS | 1.86 ± 0,13 | 1.88 ± 0.21 | 0.73 |